These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596 [TBL] [Abstract][Full Text] [Related]
7. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus. Puig M; Mihalik K; Tilton JC; Williams O; Merchlinsky M; Connors M; Feinstone SM; Major ME Hepatology; 2006 Sep; 44(3):736-45. PubMed ID: 16941702 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. Erickson AL; Houghton M; Choo QL; Weiner AJ; Ralston R; Muchmore E; Walker CM J Immunol; 1993 Oct; 151(8):4189-99. PubMed ID: 7691940 [TBL] [Abstract][Full Text] [Related]
9. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Godkin A; Jeanguet N; Thursz M; Openshaw P; Thomas H Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up after successful interferon therapy of acute hepatitis C. Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091 [TBL] [Abstract][Full Text] [Related]
11. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C. Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773 [TBL] [Abstract][Full Text] [Related]
12. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection. Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013 [TBL] [Abstract][Full Text] [Related]
13. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925 [TBL] [Abstract][Full Text] [Related]
14. HCV persistence and immune evasion in the absence of memory T cell help. Grakoui A; Shoukry NH; Woollard DJ; Han JH; Hanson HL; Ghrayeb J; Murthy KK; Rice CM; Walker CM Science; 2003 Oct; 302(5645):659-62. PubMed ID: 14576438 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection. van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746 [TBL] [Abstract][Full Text] [Related]
16. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells. Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202 [TBL] [Abstract][Full Text] [Related]
17. Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. Dutoit V; Ciuffreda D; Comte D; Gonvers JJ; Pantaleo G Eur J Immunol; 2005 Dec; 35(12):3493-504. PubMed ID: 16304636 [TBL] [Abstract][Full Text] [Related]
18. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Ciuffreda D; Comte D; Cavassini M; Giostra E; Bühler L; Perruchoud M; Heim MH; Battegay M; Genné D; Mulhaupt B; Malinverni R; Oneta C; Bernasconi E; Monnat M; Cerny A; Chuard C; Borovicka J; Mentha G; Pascual M; Gonvers JJ; Pantaleo G; Dutoit V Eur J Immunol; 2008 Oct; 38(10):2665-77. PubMed ID: 18958874 [TBL] [Abstract][Full Text] [Related]
19. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170 [TBL] [Abstract][Full Text] [Related]
20. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain. Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]